AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · IEX Real-Time Price · USD
9.89
+0.16 (1.64%)
Jul 2, 2024, 4:00 PM EDT - Market closed
AdaptHealth Market Cap
AdaptHealth has a market cap or net worth of $1.32 billion as of July 2, 2024. Its market cap has increased by 4.12% in one year.
Market Cap
1.32B
Enterprise Value
3.58B
1-Year Change
4.12%
Ranking
Category
Stock Price
$9.89
Market Cap Chart
Since February 16, 2018, AdaptHealth's market cap has increased from $312.50M to $1.32B, an increase of 321.56%. That is a compound annual growth rate of 25.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.32B | 32.50% |
| Dec 29, 2023 | 994.30M | -61.60% |
| Dec 30, 2022 | 2.59B | -19.93% |
| Dec 31, 2021 | 3.23B | -3.94% |
| Dec 31, 2020 | 3.37B | 881.23% |
| Dec 31, 2019 | 343.10M | 11.69% |
| Dec 31, 2018 | 307.20M | -1.70% |
| Feb 16, 2018 | 312.50M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Schrödinger | 1.36B |
| Avadel Pharmaceuticals | 1.36B |
| Nurix Therapeutics | 1.35B |
| ANI Pharmaceuticals | 1.33B |
| Pacira BioSciences | 1.32B |
| Kiniksa Pharmaceuticals | 1.28B |
| Verona Pharma | 1.26B |
| Spyre Therapeutics | 1.25B |